AI Article Synopsis
- Technological advancements in treating type 1 diabetes endorse modern insulin therapy methods across all medical fields, including surgery.
- Current guidelines allow for the use of continuous subcutaneous insulin infusion during minor surgeries, but there are limited examples of hybrid closed-loop systems being applied.
- This case study highlights two children with type 1 diabetes successfully managed with an advanced hybrid closed-loop system during a minor surgical procedure, achieving recommended blood sugar levels throughout the process.
Article Abstract
Technological progress in the treatment of type 1 diabetes requires doctors to use modern methods of insulin therapy in all areas of medicine that patients may come into contact with, including surgical interventions. The current guidelines indicate the possibility of using continuous subcutaneous insulin infusion in minor surgical procedures, but there are few reported cases of using a hybrid closed-loop system in perioperative insulin therapy. This case presentation focuses on two children with type 1 diabetes who were treated with an advanced hybrid closed-loop (AHCL) system during a minor surgical procedure. In the periprocedural period, the recommended mean glycemia and the time in range were maintained.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9957216 | PMC |
| http://dx.doi.org/10.3390/healthcare11040587 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Duration of physical activity required to Ameliorate hyperglycemia without causing hypoglycemia in type 1 diabetes: A T1DEXI adults and pediatric cohort analyses.
Diabetes Res Clin Pract
December 2024
School of Kinesiology and Health Science, York University, Toronto, ON, Canada. Electronic address:
Aims: To estimate physical activity (activity) duration required to lower glucose from above target range (>180 mg/dL) to within target range (TIR: 70-180 mg/dL) in individuals with type 1 diabetes (T1D).
Methods: Continuous glucose monitoring and activity data were collected from 404 adults (28-day observation) and 149 adolescents (10-day observation) with T1D. Activities (N = 1902) with a starting glucose between 181-300 mg/dL, duration 10-60 min, and no reported meals during activity were included in the analysis.
Strategic model for integrating biogas a framework for sustainable energy integration in agro-industries.
Sci Rep
December 2024
Industrial and Systems Engineering Department, Institut Teknologi Sepuluh Nopember, Surabaya, Indonesia.
The framework of the methodology presented in this study is an effort to integrate and optimize the agro-industry sector, especially energy in biogas. In this study, the technique of the system in functional analysis is shown systematically to translate various energy requirements in the factory as criteria for performance and functional design to be integrated, optimized, and energy efficient. The case study results indicated that biogas power plants, with a capacity of 1.
View Article and Find Full Text PDFEnhanced Metabolic Control in a Pediatric Population with Type 1 Diabetes Mellitus Using Hybrid Closed-Loop and Predictive Low-Glucose Suspend Insulin Pump Treatments.
Pediatr Rep
December 2024
Department of Endocrinology, Diabetes Mellitus, Nutrition and Metabolic Disorders, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Background: Insulin pumps coupled with continuous glucose monitoring sensors use algorithms to analyze real-time blood glucose levels. This allows for the suspension of insulin administration before hypoglycemic thresholds are reached or for adaptive tuning in hybrid closed-loop systems. This longitudinal retrospective study aims to analyze real-world glycemic outcomes in a pediatric population transitioning to such devices.
View Article and Find Full Text PDFSwitching from open-source to commercial advanced automated insulin delivery system: glucose management and patient perspective in an adult living with type 1 diabetes.
Can J Diabetes
December 2024
Montreal Clinical Research Institute, 110 Pine Ave W, Montreal, Quebec, H2W 1R7, Canada; Division of Experimental Medicine, Department of Medicine, McGill University, 845 Sherbrooke St W, Montreal, Quebec H3A 0G4, Canada.
Experience of People with Diabetes Treated with Insulin Delivery Systems in France: A Comparative Analysis of Multiple Daily Injections, Tubeless Pumps, Tubed Pumps, and Hybrid Closed Loops.
Diabetes Ther
December 2024
IMMEDIAB Laboratory, Institut Necker Enfants Malades, INSERM U1151, CNRS, UMR 8253, Paris, France.
Introduction: While people with diabetes (PWD)'s experiences with their insulin delivery systems (IDS) are frequently reported in clinical trials, few real-world data exist on the subject. This study aimed to assess the real-world experience and satisfaction with IDS in PWD.
Methods: This cross-sectional survey of PWD treated with tubed or tubeless insulin pumps, hybrid closed loop (HCL) systems, or multiple daily injections (MDI) for at least 3 months ran from 4 to 16 May 2023.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!